Trials / Sponsors / Progen Pharmaceuticals
Progen Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma Cancer, Liver Cancer, Primary Liver Cancer | Phase 3 | 2007-12-01 |
| Completed | Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD Age Related Macular Degeneration | Phase 1 | 2007-04-01 |
| Completed | Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab Cancer | Phase 1 | 2006-05-01 |
| Completed | SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma Lymphoma | Phase 1 | 2006-01-01 |
| Completed | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer Prostate Cancer | Phase 2 | 2005-08-01 |
| Completed | Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors Cancer | Phase 1 | 2005-03-01 |